The advanced autoantibody panel, Neural Zoomer Plus , screens for immune reactivity to key neural targets, including myelin basic protein, NMDA receptors, gangliosides, synapsin, S100B, and blood-brain barrier proteins
Modern Commercial Expansion Epithalon entered online peptide markets despite the absence of a conventional clinical-development programme establishing human pharmacokinetics, safety and effectiveness
Large doses of niacin reduce urinary excretion of uric acid, potentially causing hyperuricemia
A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study
Xi'an Sonwu is looking forward to hearing from you
Talk with a licensed clinician before using any peptide, supplement, or drug